Stop Press
Home Up regsCEne Stop Press R&D Digest Meetings Marketinfo Market Debris

Media Briefing
Bio-skin
Bio-skin FAQ


RSA announces The Onians Fellowship

The London-based Royal Society for the encouragement of Arts, Manufactures & Commerce (RSA) has recently announced the establishment of fellowships in the name of a past Chairman, Dick Onians.

The closing date for the first award is the FIRST WEEK OF JULY 2000 and application forms are available from the RSA web-site at www.rsa.org.uk/onians. The application forms can be filled out after down-loading and should be returned by E-mail to onians@rsa-uk.demon.co.uk. Final interviews will take place in August 2000 with a target for the start of a fellowship of September 2000.

The fellowships are aimed at anyone who has worked and achieved in their field, including those without formal qualifications, who have creative ideas and want to make an innovative approach to challenges in one of three areas:

·      encouragement of successful businesses, development of more supportive entrepreneurial environment and more effective funding systems, with a focus on (though not exclusively) enabling young people to set up their own businesses;

·      encouraging better science, technology or mathematics teaching in schools or better ways of educating young managers;

·      tourism and new ways of creating new businesses in rural areas.

The fellowships are worth up to £27,000 (45000 EURO) over a period of up to 2 years and are open to any age of applicant, although those under the age of 40 will be especially welcomed. Applicants from outside the UK are also welcome, but must complete their application form in English.

Editor's comment: Many of the challenges facing the design, development and introduction of new biomaterials and tissue engineering into human medicine and into the social and economic aspects of our national cultures require innovative approaches. Please take advantage of this unique opportunity to obtain support for your own creative thoughts, innovative ideas and practical projects. Meredith Lloyd-Evans June 2000

 

  • On April 13th 2000 in Brussels, the European Commission held a Media briefing on four European projects in biomaterials, three of them from the European Biomaterials Network, that are achieving, or have achieved, remarkable results. Entitled 'Building a bionic body? Biomaterials research for healthcare', the day was introduced by the EU’s Research Commissioner, Philippe Busquin. The EBN projects included BE-4612, led by Professor C van Blitterswijk and Dr J de Bruijn of IsoTis BV, BE-3524, led by Dr Alessandra Pavesio of the Italian company FAB and BE-4329, led by Dr Thomas Groth of GKSS Germany, who presented the results of the work of the project consortia on bioengineered bone tissue, skin and biomembranes for artificial organs. The PHIDIAS consortium project was also presented, at a site visit in Leuven. PHIDIAS is dedicated to computer-aided capture of essential information for surgeons, allowing rapid prototyping and improved surgical placements for implants. M. Busquin said, ' There are over 100,000 hip revision operations per annum carried out world-wide, over half of which occur in the EU. Around 1% of the world-wide population is affected at any one time by leg ulcers, approximately 2 million of which are the result of diabetes. World-wide there are over 50,000 cases per annum of serious burns, one of the worst traumas the body can suffer and approximately 10% of which result in death. Haemodialysis, as a result of organ failure, is required by several hundreds of thousand Europeans. In addition to the seriously decreased quality of life and low life expectancy of these patients, costs for treatment per patient are as much as 50.000 Euro per year. Improved design methodologies for complex components, which assist the development of custom-made implants and success of difficult surgical techniques, will go some way to reducing suffering of patients and will decrease European healthcare costs. We all wish for our children and grandchildren to live better lives than our parents and grandparents. These projects, and those like them, go some way to making these wishes become true.' Click here for a background press release on the briefing. Information on the meeting can also be obtained from Stephen.Gosden@cec.eu.int or Michael-Cristian.Delle-Selve@cec.eu.int

More details on BE-3524, bioengineered skin, and background information on skin reconstruction can be found through the links.

  • The UK EPSRC has published its second call for proposals relating to engineering and innovation in healthcare, at http://www.epsrc.ac.uk/documents/support_for_researchers/calls_for_proposals/engman/abinhet2_nw0.htm  or via the  main Engineering For Manufacturing page at  http://www.epsrc.ac.uk/EPSRCWEB/MAIN/PROGRAMMES/PROGRAMMES/Intro/Intro_EM.asp  From there, select "Calls for Proposals" and then the IntHeTech 2nd Call.  The call includes links to the original ROAME Statement and the Managed  Programme Outline Form which will have to be completed by all proposers.  For further details contact the manager, Oliver Wells  Tel: +44 (0)1483 428909 Mob: +44 (0)7771 598644 Email oliwells@aol.com

  • At the 28th International Exhibition for Inventions, New Technologies and Products, W Roth, the Managing Director of Erothitan Titanimplante GmbH, received a Gold Medal on behalf of the Laserapatite consortium, an EC-funded project, several members of which, including Erothitan and the University of Vigo, are also members of the European Biomaterials Network. The award is presented by the Thuringian Inventor's Center and the German Government.

  • Greetings Meredith, Is it possible you could advertise two meetings for me on your web site. I have now made a link on my groups homepage to your web page under interesting links http://www.ao-asif.ch/ari/research/interface/links.html

Back Up Next

 

All text and representations on this site © L P M Lloyd-Evans & BioBridge 2000-2005
mlloydevans@biobridge.co.uk.
Designed and managed by BioPortfolio Ltd on behalf of  L P M Lloyd-Evans & BioBridge Associates.

The foundation and maintenance of this site was made possible by EC funding in project BRRT-CT97-5008 1997-2000